A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer

Study summary

Eligible lung cancer patients: Undergo pre-treatment 4D-CT study for treatment planning External Beam Radiation: standard fractionation (2Gy per day) or stereotactic body radiation therapy Evaluation: Repeat 4D-CT study at 3 months and 6 months post-treatment Primary objectives: To assess pre-treatment global and focal lung strain and correlate with changes post-treatment

Ask AI to explain this study

Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studied4D-CT pre-treatment scan

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 22, 2021 · Source: ClinicalTrials.gov

Is enrollment open?Unknown

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Louisville

Study sponsor

Study overview

What this study is about

Purpose: Treatment
Study type: Interventional
Phase: Not applicable
Sponsor: University of Louisville
Interventions being studied: Radiation: 4D-CT pre-treatment scan

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Radiation therapy→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Age \>/= 18 years 2. ECOG performance status 0-1 3. Pathologic or clinical diagnosis of lung malignancy 4. Patients must have a reproducible tidal volume sufficient for 4D-CT imaging 5. Negative serum pregnancy test within 2 weeks prior to registration for women of childbearing potential. 6. Women of childbearing potential and male participants who are sexually active must agree to use a medically effective means of birth control 7. Patients must provide study specific informed consent prior to study entry.

Reasons someone may not be able to joinExclusion criteria

1. Patients with severe pulmonary dysfunction with non-reproducible tidal volumes sufficient for 4D-CT imaging. 2. Pregnant women or lactating women

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

James Graham Brown Cancer CenterLouisville, Kentucky

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 22, 2021. Always confirm current availability with the study team.

View original record ↗